These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol. Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK; Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987 [TBL] [Abstract][Full Text] [Related]
25. Hypersensitivity to different polyethylene glycol-containing products. Khalid MB; Bundy V Ann Allergy Asthma Immunol; 2021 Jun; 126(6):734-735. PubMed ID: 33716148 [No Abstract] [Full Text] [Related]
26. Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses. Burke PW; Aldoss I; Lunning MA; Devlin SM; Tallman MS; Pullarkat V; Mohrbacher AM; Douer D Leuk Res; 2018 Mar; 66():49-56. PubMed ID: 29407583 [TBL] [Abstract][Full Text] [Related]
27. Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. Losasso M; Bostrom B; Messinger Y F1000Res; 2019; 8():1007. PubMed ID: 32089823 [No Abstract] [Full Text] [Related]
28. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614 [TBL] [Abstract][Full Text] [Related]
29. Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia. Geyer MB; Ritchie EK; Rao AV; Vemuri S; Flynn J; Hsu M; Devlin SM; Roshal M; Gao Q; Shukla M; Salcedo JM; Maslak P; Tallman MS; Douer D; Park JH Haematologica; 2021 Aug; 106(8):2086-2094. PubMed ID: 33054114 [TBL] [Abstract][Full Text] [Related]
30. Vitreous injections of pegaptanib sodium triggering allergic reactions. Steffensmeier AC; Azar AE; Fuller JJ; Muller BA; Russell SR Am J Ophthalmol; 2007 Mar; 143(3):512-3. PubMed ID: 17317399 [TBL] [Abstract][Full Text] [Related]
31. Selective hypersensitivity to diclofenac. del Pozo MD; Lobera T; Blasco A Allergy; 2000 Apr; 55(4):412-3. PubMed ID: 10782536 [No Abstract] [Full Text] [Related]
32. Predicting success of desensitization after pegaspargase allergy. Swanson HD; Panetta JC; Barker PJ; Liu Y; Inaba H; Relling MV; Pui CH; Karol SE Blood; 2020 Jan; 135(1):71-75. PubMed ID: 31750901 [No Abstract] [Full Text] [Related]
33. Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review. Abbott LS; Zakova M; Shaikh F; Shewaramani N; Punnett A; Dupuis LL Paediatr Drugs; 2015 Aug; 17(4):315-21. PubMed ID: 25862348 [TBL] [Abstract][Full Text] [Related]
34. Pegaspargase: a review of clinical studies. Graham ML Adv Drug Deliv Rev; 2003 Sep; 55(10):1293-302. PubMed ID: 14499708 [TBL] [Abstract][Full Text] [Related]
35. Pegaspargase versus asparaginase in adult ALL: a pharmacoeconomic assessment. Peters BG; Goeckner BJ; Ponzillo JJ; Velasquez WS; Wilson AL Formulary; 1995 Jul; 30(7):388-93. PubMed ID: 10151730 [TBL] [Abstract][Full Text] [Related]
36. Pegaspargase: an alternative? Holle LM Ann Pharmacother; 1997 May; 31(5):616-24. PubMed ID: 9161659 [TBL] [Abstract][Full Text] [Related]
37. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified. Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343 [TBL] [Abstract][Full Text] [Related]
38. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA. Keating GM BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007 [TBL] [Abstract][Full Text] [Related]
39. Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06. Albertsen BK; Harila-Saari A; Jahnukainen K; Lähteenmäki P; Riikonen P; Möttönen M; Lausen B Leuk Lymphoma; 2019 Jun; 60(6):1469-1475. PubMed ID: 30632847 [TBL] [Abstract][Full Text] [Related]
40. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; Camitta BM J Pediatr Hematol Oncol; 2011 Dec; 33(8):610-6. PubMed ID: 22042277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]